AIM ImmunoTech Inc. (AIM) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Aim Immunotech Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:04.431 Hello and welcome to the AIM Immunotech second quarter 2024 update 00:00:04.431 -- 00:00:06.792 conference call and webcast. 00:00:06.792 -- 00:00:11.493 As a brief reminder, all participants are currently in a listen-only mode. 00:00:11.493 -- 00:00:15.515 If anyone requires operator assistance during the event, please press star zero on your 00:00:15.515 -- 00:00:17.916 telephone keypad. 00:00:17.916 -- 00:00:21.657 Following the presentation will be a question and answer session. 00:00:21.657 -- 00:00:25.859 Note that this webcast is being recorded at the company's request and a replay will be 00:00:25.859 -- 00:00:30.894 made available on the company's website following the end of the event. 00:00:30.894 -- 00:00:34.637 At this time, I'd like to remind our listeners that remarks made during this webcast 00:00:34.637 -- 00:00:39.762 may state management's intentions, beliefs, expectations, or future projections. 00:00:39.762 -- 00:00:43.826 These are forward-looking statements and involve risks and uncertainties. 00:00:43.826 -- 00:00:47.569 Forward-looking statements on this call are made pursuant to the safe harbor provisions 00:00:47.569 -- 00:00:53.094 of the federal securities laws and are based on AIM Immunotech's current expectations, 00:00:53.094 -- 00:00:56.415 and actual results could differ materially. 00:00:56.508 -- 00:01:01.732 As a result, you should not place under-reliance on any forward-looking statements. 00:01:01.732 -- 00:01:06.435 Some of the factors that could cause actual results to differ materially from these contemplated 00:01:06.435 -- 00:01:11.519 by such forward-looking statements are discussed in the periodic reports in MUNITEC files 00:01:11.519 -- 00:01:13.961 with the Securities and Exchange Com...